ReShape Lifesciences and Vyome Therapeutics Complete Merger; Will Trade as Vyome Holdings (HIND)

Syros Pharmaceuticals Merges with TYME Technologies

September 16, 2022

Biotechnology

Syros Pharmaceuticals completed a merger with TYME Technologies, acquiring TYME's pipeline assets and approximately $60 million of net cash at closing. The transaction was accompanied by an oversubscribed $130 million PIPE financing to provide capital for Syros' late-stage hematology programs and early commercialization activities.

Viveon Health Acquisition Corp. to Merge with Suneva Medical

January 12, 2022

Medical Devices

Suneva Medical, a San Diego–based regenerative aesthetics medical technology company, has entered into a definitive merger agreement with special purpose acquisition company Viveon Health Acquisition Corp. The transaction will combine Suneva with the public SPAC vehicle (NYSE American: VHAQ) to provide growth capital and public-market access for Suneva, with the combined company expected to trade on the NYSE under the symbol "RNEW."

Tome Biosciences Acquires Replace Therapeutics

January 5, 2024

Biotechnology

Tome Biosciences has acquired Replace Therapeutics in a merger valued at $65 million in up-front and near-term milestones and up to $185 million total through a mix of cash and stock. Replace will become a wholly owned subsidiary of Tome, adding its ligase-mediated programmable genomic integration (L-PGI) technology to complement Tome's large-DNA integrase-mediated PGI platform to expand the company's gene‑editing capabilities.

Lomond Therapeutics Completes Reverse Merger with Venetian-1 and Raises $44M

November 4, 2024

Biotechnology

Lomond Therapeutics completed a reverse merger with Venetian-1 Acquisition Corp., which changed its name to Lomond Therapeutics Holdings, Inc., and closed a $44 million private placement led by existing and new investors. The financing included participation from OrbiMed, Torrey Pines Investment, Deerfield Management, American Financial Group and Heights Capital and will fund advancement of Lomond’s clinical-stage oncology programs (lomonitinib, lonitoclax and a menin inhibitor).

Viome Life Sciences Acquires Naring Health (including DiscernDX and Foodome)

November 2, 2023

Healthcare Services

Viome Life Sciences has acquired digital health startup Naring Health, including its subsidiaries DiscernDX and Foodome, to expand its capabilities in multi-omics, diagnostics and precision nutrition. The deal brings together microbiome analysis, proteomics and foodomics capabilities to enhance Viome's personalized nutrition and early disease detection offerings.

BioMatrix Infusion Pharmacy Acquires MyLyfe Health

March 3, 2025

Healthcare Services

BioMatrix Infusion Pharmacy, a nationwide specialty infusion pharmacy based in Plantation, Florida, has acquired MyLyfe Health, a New England–based specialty pharmacy and home infusion services provider. The acquisition expands BioMatrix's geographic footprint into New England and enhances its ambulatory and home infusion capabilities to better serve patients with chronic, lifelong conditions.